Indian biotech firm Stempeutics Research gets China Patent for its novel stem cell drug

Bengaluru: Stempeutics Research has been granted a process patent for its stem-cell based drug Stempeucel by the State Intellectual Property Office of the People’s Republic of China. Stempeutics has become the first company in the world to be granted a patent by the Chinese patent office.

…read more

Source:: http://www.ibef.org/news/indian-biotech-firm-stempeutics-research-gets-china-patent

Become a member

The NICCT informs its members about relevant business developments in India and the Netherlands. The NICCT also inspires its members by organizing various programs throughout the year and providing the opportunity for you to meet your peers and build your network. We are also influencing relevant stakeholders to optimize business relations between the Netherlands and India. By doing this we promote business and economic relations between India and the Netherlands to the mutual benefit of both countries.

News URL